New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies

Keywords

Medicine

References

• Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.Wenying Wang, Meng‐Shan Tan, Jin‐Tai Yu — 2015
• Multiple roles of eph receptors and ephrins in neural developmentDavid G. Wilkinson — 2001
• Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells.Christer Nordstedt, Gregg L. Caporaso, J Thyberg — 1993
• Review: The genetics of Alzheimer's disease; putting flesh on the bonesChristopher Medway, Kevin Morgan — 2014
• Effect of EPHA1 Genetic Variation on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease CohortsHui-Fu Wang, for the Alzheimer's Disease Neuroimaging Initiative, Lan Tan — 2015
• TREM2 protein expression changes correlate with Alzheimer’s disease neurodegenerative pathologies in postmortem temporal corticesLih‐Fen Lue, Christopher T. Schmitz, Geidy E. Serrano — 2014
• The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer’s DiseaseAmy Gerrish, Giancarlo Russo, Alexander Richards — 2012
• Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer diseaseMadhav Thambisetty, Andrew Simmons, Latha Velayudhan — 2010
• The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.Patricia B. Furtado, Chen Y. Huang, Demvihin Ihyembe — 2008
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s diseaseAdam C. Naj, Gyungah Jun, Gary W. Beecham — 2011
• Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-PeptideBonnie M. Bradt, William P. Kolb, Neil R. Cooper — 1998
• Influx of extracellular calcium participates in rituximab-enhanced ionizing radiation-induced apoptosis in Raji cells.Min Fengling, Gao Qingxiang, Zhai Lijia — 2012
• Amyloid Precursor Protein Trafficking, Processing, and Function*Gopal Thinakaran, Edward H. Koo — 2008
• Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer’s diseaseYen‐Ling Lin, Shih‐Yuan Chen, Liang‐Chuan Lai — 2012
• Siglecs and their roles in the immune systemPaul R. Crocker, James C. Paulson, Ajit Varki — 2007
• BIN1 is a novel MYC–interacting protein with features of a tumour suppressorDaitoku Sakamuro, Katharine J. Elliott, Robert J. Wechsler‐Reya — 1996
• The non-classical functions of the classical complement pathway recognition subcomponent C1q.Annapurna Nayak, J. Ferluga, Anthony G. Tsolaki — 2010
• Association of GWAS Top Hits With Late-onset Alzheimer Disease in Korean PopulationSun Ju Chung, Jae‐Hong Lee, Seong Yoon Kim — 2013
• High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytesYolanda González, María Teresa Herrera, Gloria Soldevila — 2012
• Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release.Yuika Ikeda, Sumiko Abe-Dohmae, Youichi Munehira — 2003

Cited by

• Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease.Zdeněk Fišar, Roman Jirák, Martina Zvěřová — 2019
• Formaldehyde, Epigenetics, and Alzheimer’s DiseaseFei Wang, Danqi Chen, Peipei Wu — 2019
• Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.Claudia Cannavo, Justin Tosh, Elizabeth Fisher — 2020
• The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid AngiopathyPablo Cisternas, Xavier Taylor, Cristian A. Lasagna‐Reeves — 2019
• Parkinson disease and the immune system — associations, mechanisms and therapeuticsEng‐King Tan, Yinxia Chao, Andrew B. West — 2020
• The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic BiomarkersChiara Argentati, Ilaria Tortorella, Martina Bazzucchi — 2020
• Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer’s DiseaseReagon Karki, Sumit Madan, Yojana Gadiya — 2020
• Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and DiseaseEsther C. W. de Boer, Anouk G. van Mourik, Ilse Jongerius — 2020
• Gauging the role and impact of drug interactions and repurposing in neurodegenerative disordersDharmendra Kumar Khatri, Amey Kadbhane, Monica Patel — 2021
• Neuroinflammation in Alzheimer’s DiseaseIsaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná — 2021
• Disease-specific interactome alterations via epichaperomics: the case for Alzheimer’s diseaseStephen D. Ginsberg, Thomas A. Neubert, Sahil Sharma — 2021
• Progression in Alzheimer’s Disease Correlates With Epigenetics and Cerebral Formaldehyde: From Potential Hereditary Mechanism and Environmental Factors to Therapeutic MeasuresMohit Pant, Siddhartha Dan, Sujata Pant — 2021
• Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of TREM2 in Alzheimer’s Disease by Splicing-Based AggregationSeonggyun Han, Yirang Na, InSong Koh — 2021
• Remembering your A, B, C's: Alzheimer's disease and ABCA1Cutler T. Lewandowski, Megan S. Laham, Gregory R. J. Thatcher — 2022
• Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer’s disease mouse modelLaura K. Hamilton, Gaël Moquin‐Beaudry, C. Mangahas — 2022
• Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s DiseasePing Liu, Yunyun Wang, Yan Sun — 2022
• Inflammation—Cause or consequence of late onset Alzheimer’s disease or both? A review of the evidenceJinrong Zhao, Dong Zhao, Jinpei Wang — 2022
• Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s diseaseDeepali Singh — 2022
• Brain structure and allelic associations in Alzheimer's diseaseSeok Woo Moon, Lu Zhao, William Matloff — 2022
• Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?Oualid Sbai, Veronica Bazzani, Shreya Tapaswi — 2023

Related papers

No related papers recorded.